{"references": [{"fullname_first_author": "Giacomo Aletti", "paper_title": "Nonparametric covariate-adjusted response-adaptive design based on a functional urn model", "publication_date": "2018-01-01", "reason": "This paper is foundational for the development of nonparametric covariate-adjusted response-adaptive designs, which are the focus of the current paper."}, {"fullname_first_author": "Arielle Anderer", "paper_title": "Adaptive clinical trial designs with surrogates: When should we bother?", "publication_date": "2022-01-01", "reason": "This paper directly addresses the use of surrogates in adaptive clinical trials, a key aspect of the current paper's methodology."}, {"fullname_first_author": "Susan Athey", "paper_title": "Combining experimental and observational data to estimate treatment effects on long term outcomes", "publication_date": "2020-01-01", "reason": "This paper tackles the challenges of estimating long-term treatment effects, a central issue in the context of delayed outcomes addressed by the current paper."}, {"fullname_first_author": "Susan Athey", "paper_title": "The surrogate index: Combining short-term proxies to estimate long-term treatment effects more rapidly and precisely", "publication_date": "2019-01-01", "reason": "This paper introduces the concept of a surrogate index, which is highly relevant to the current paper's use of surrogate outcomes in improving efficiency."}, {"fullname_first_author": "David J Benjamin", "paper_title": "FDA decisions on new oncological drugs", "publication_date": "2022-01-01", "reason": "This paper discusses FDA approval processes based on surrogate endpoints, which is directly relevant to the regulatory context of clinical trials with delayed outcomes."}]}